PDF herunterladen
Hamostaseologie 1986; 06(01): 38-43
DOI: 10.1055/s-0038-1655136
Originalarbeiten
Schattauer GmbH

Zur Therapie der Immunthrombozytopenie

W. Schramm
1   Med. Klinik Innenstadt der Universität München
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
25. Juni 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • Literatur

  • 1 Abe T, Matsuda J, Kawasugi K, Yoshimura Y, Kinoshita T, Kazama M. Clinical effect of intravenous immun globulin on chronic idiopathic thrombocytopenic purpura. Blut 1983; 47: 69-75.
    CrossrefPubMedGoogle Scholar
  • 2 Ahn Y S, Harrington W J, Seelman R C. Vincristine therapy of idiopathic and secondary thrombozytopenias. N Engl J Med 1974; 291: 376-80.
    CrossrefPubMedGoogle Scholar
  • 3 Ahn Y S, Harrington W J, Simon S R. et al. Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983; 308: 1396-9.
    CrossrefPubMedGoogle Scholar
  • 4 Aster R H. Thrombozytopenia due to enhanced platelet destruction. In: Williams W J. et al. (Eds): Hematology. 2nd ed. McGraw Hill; New York: 1977: 1326-60.
    Google Scholar
  • 5 Bierling P, Farcet J P, Dvedari N, Rochant H. Gamma globulin for idiopathic thrombocytopenic purpura. N Engl J Med 1982; 307: 1150-1.
    CrossrefPubMedGoogle Scholar
  • 6 Bierling P, Farcet J P, Dvedari N, Rochant H. Increased-platelet-associated IgG in patient on high-dose gamma globulin for autoimmune thrombocytopenic purpura. Lancet 1982; II: 388.
    PubMedGoogle Scholar
  • 7 Bondolfi R, Hirt A, Morell A, Barandun S. Autoimmunhaemolytische Anämie bei congenitaler Agammaglobulinaemie. Behandlungserfolg durch Immunglobulin-Substitution. Schweiz Med Wschr 1980; 110: 1950.
    PubMedGoogle Scholar
  • 8 Brennan M F, Rappeport J M, Moloney W C, Wilson R E. Correlation between response to cortisteroids and splenectomy for adult idiopathic thrombocytopenic purpura. Am J Surg 1975; 129: 490-2.
    CrossrefPubMedGoogle Scholar
  • 9 Bussel J B, Kimberly R P, Inman R D. et al. Intravenous gamma globulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983; 62: 480-6.
    PubMedGoogle Scholar
  • 10 Caplan S N, Berkman E M. Immunosuppressive therapy of idiopathic thrombocytopenic purpura. Med Clin N Am 1976; 60: 971-86.
    CrossrefPubMedGoogle Scholar
  • 11 Carroll R R, Noyes W D, Kitchens C S. High-dose intravenous immunoglobulin therapy in patients with immune thrombocytopenic purpura. JAMA 1983; 249: 1748-50.
    CrossrefPubMedGoogle Scholar
  • 12 Coller B S. Disorders of Platelets. Disorders of Hemostasis 1984; 73-177.
    PubMedGoogle Scholar
  • 13 Dameshek W, Rubio Jr F, Mahoney J P. Treatment of idiopathic thrombozytopenic purpura with prednisone. J Amer med Ass 1958; 166: 1805-15.
    CrossrefPubMedGoogle Scholar
  • 14 Dameshek W, Ebbe S, Greenberg J, Baldini M. Recurrent acute idiopathic thrombozytopenic purpura. N Engl J Med 1963; 269: 647.
    CrossrefPubMedGoogle Scholar
  • 15 DiFino S M, Lachant N A, Kirshner J J, Gottlieb A J. Adult idiopathic thrombocytopenic purpura: clinical findings and response to therapy. Am J Med 1980; 69: 430-42.
    CrossrefPubMedGoogle Scholar
  • 16 DiFino S M, Lachant N A, Kirshner J J, Gottlieb A J. Adult idiopathic thrombocytopenic purpura: clinical findings and response to therapy. Am J Med 1980; 69: 430-42.
    CrossrefPubMedGoogle Scholar
  • 17 Doan C A, Bouroncle B A, Wiseman B K. Idiopathic and secondary thrombozytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Int Med 1960; 53: 861-76.
    CrossrefPubMedGoogle Scholar
  • 18 Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982; 306: 1254-8.
    CrossrefPubMedGoogle Scholar
  • 19 Finch S C, Castro O, Cooper M. et al. Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 1974; 56: 4-12.
    CrossrefPubMedGoogle Scholar
  • 20 Gaedicke G, Imbach P, Küenzlen E, Kleihauer E. Kontroversen in der Therapie der Immunthrombozytopenie des Kindesalters. Dtsch med Wschr 1985; 110: 1340-5.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 21 Gaedicke G, Imbach P, Kleihauer E. The place of intravenous immunoglobulin (IgG i.v.) therapy in thrombocytopenia. Blut 1984; 48: 409-13.
    CrossrefPubMedGoogle Scholar
  • 22 Gaedicke G, Imbach P, Küenzlen E, Kleihauer E. Kontroversen in der Therapie der Immunthrombozytopenie des Kindesalters. Dtsch med Wschr 1985; 110: 1340-5.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 23 Gardi A. Quality control in the Production of an Immunoglobulin for intravenous use. Blut 1984; 48: 337-44.
    CrossrefPubMedGoogle Scholar
  • 24 Gugler E. Die kindlichen Thrombopenien. Rossi E. (ed) Päd Fortbildk. 1964. Vol. 11-12 143.
    Google Scholar
  • 25 Henoch E. Vorlesungen über Kinderkrankheiten. 10. Aufl. August Hirschwald, Berlin: 1899
    Google Scholar
  • 26 Imbach P, Luginbühl L, Späth P, Hirt A, Huwyler T, Morell A, Mueller-Eckhardt C, Pichler W J, Wagner H P. Ciclosporin (CyA) and intravenous immuneglobulin (i. v. IgG) in chronic immune thrombocytopenic purpura (ITP) in childhood: a clinical and immunological study (progress report) Ciclosporin in Autoimmune Diseases. Schindler R. (Ed). Springer, Berlin: 1985: 268.
    Google Scholar
  • 27 Imbach P, Barandun S, d’Apuzzo V. et al. High-dose intravenous gamma globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; I: 1228-31.
    PubMedGoogle Scholar
  • 28 Imbach P, Barandun S, Baumgartner C, Hirt A, Hofer F, Wagner H P. High-dose intravenous gamma globulin therapy of refractory in particular idiopathic thrombocytopenia in childhood. Helv Paediat Acta 1981; 46: 81-6.
    PubMedGoogle Scholar
  • 29 Imbach P, Berchtold W, Hirt A, MuellerEckhardt C, Rossi E, Wagner H P, Gaedikke G, Joller P, Müller B, Barandun S. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985; II: 464-8.
    PubMedGoogle Scholar
  • 30 Imbach P, Jungi T W. Possible Mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP). Blut 1983; 46: 117-24.
    CrossrefPubMedGoogle Scholar
  • 31 Imbach P, Gaedicke G, Joller P. Interim evaluation of two cooperative studies assessing the effects of intravenous immunglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP). Blut 1984; 48: 357-61.
    CrossrefPubMedGoogle Scholar
  • 32 Jiji R M, Firozvi T, Spurling C L. Chronic idiopathic thrombozytopenic purpura. Treatment with steroids and splenectomy. Arch Int Med 1973; 132: 380-3.
    CrossrefPubMedGoogle Scholar
  • 33 Jungi T W, Imbach P, Barandun S. Specific and nonspecific mechanisms of action of Immunoglobulin G in therapy of idiopathic thrombocytopenic purpura (ITP). Blut 1984; 48: 345-51.
    CrossrefPubMedGoogle Scholar
  • 34 Kapatkin S. Autoimmune thrombozytopenic purpura. Blood 1980; 56: 329-43.
    PubMedGoogle Scholar
  • 35 Kaznelson P. Verschwinden der hämorrhagischen Diathese bei einem Falle von essentieller Thrombopenie nach Milzexstirpation. Vienna Clin Wschr 1916; 29: 1451-4.
    PubMedGoogle Scholar
  • 36 Laros R K, Penner J A. “Refractory” thrombocytopenia purpura treated successfully with cyclophosphamide. J Am Med Ass 1971; 215: 445-9.
    CrossrefPubMedGoogle Scholar
  • 37 Lever A M L, Brown D, Webster A D B, Thomas H C. Non-A, Non-B Hepatitis occurring in Agammaglobulinaemie patients after intravenous immunoglobulin. Lancet 1984; 10: 1062-4.
    PubMedGoogle Scholar
  • 38 Lusher J M, Iyer R. Idiopathic thrombozytopenic purpura in children. Semin Thrombos Hemostas 1977; 03: 75.
    PubMedGoogle Scholar
  • 39 Lusher J M, Emani A, Ravindranath Y, Warrier A J. Idiopathic thrombozytopenic purpura in children. Am J pediat Hemat Oncol 1984; 06: 149.
    PubMedGoogle Scholar
  • 40 Marx R. Behandlung von Thrombozytopenien. Therapiewoche 1967; 17: 22 737.
    PubMedGoogle Scholar
  • 41 Masson P L. The therapeutic use of human immunoglobulin selected on the basis of their antibody activity against circulating antigens. Peeters H, Wright P. (Eds). Plasma Protein Pathology. Pergamon; Oxford: 1979
    Google Scholar
  • 42 McClure P. Idiopathic thrombozytopenic purpura in children; should corticosteroids be given?. Am J Dis Child 1977; 131: 357.
    CrossrefPubMedGoogle Scholar
  • 43 McElfresh A E. Idiopathic thrombozytopenic purpura: to treat or not to treat?. J Pediat 1975; 87: 160.
    CrossrefPubMedGoogle Scholar
  • 44 McMillan R. Chronic idiopathic thrombozytopenic purpura. N Engl J Med 1981; 304: 1135-47.
    CrossrefPubMedGoogle Scholar
  • 45 Meyers C M. Results of treatment in 71 patients with idiopathic thrombocytopenic purpura. Am J Med Sciences 1961; 242: 295-302.
    CrossrefPubMedGoogle Scholar
  • 46 Morse B S, Guiliani D, Nussbaum M. Quantitation of platelet-associated IgG by radial immunodiffusion. Blood 1981; 57: 809-11.
    PubMedGoogle Scholar
  • 47 Mueller-Eckhardt C. Recent advances in the treatment of immune thrombocytopenia. Xth International Congress on Thrombosis and Haemostasis 1985. Thrombos Haemostas 1985; 54: 115.
    PubMedGoogle Scholar
  • 48 Mueller-Eckhardt C, Salama A, Kiefel V, Kiienzlen E, Förster C. A new concept for the effector mechanism of intravenous immunoglobulin in Hemocytopenias. Blut 1984; 48: 353-6.
    CrossrefPubMedGoogle Scholar
  • 49 Newland A C, Treleaven J C, Michinton R M, Waters A H. High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet 1983; I: 84-7.
    PubMedGoogle Scholar
  • 50 Oral A, Nusbacher J, Hill J B, Lewis J H. Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults. Am J Med March 1984; 30: 187-92.
    PubMedGoogle Scholar
  • 51 Orosz C G, Fidelus R K, Roopenian D C, Widmer M B, Ferguson R M, Bach F H. A new immunosuppressive mechanism for cyclosporin A demonstrated with cloned T-lymphocytes. Transplant Proc 1983; 15: 1927-9.
    PubMedGoogle Scholar
  • 52 Ring J, Duswald K H. Klin Wschr. 1980; 58: 797.
    PubMedGoogle Scholar
  • 53 Rosse W F. Treatment of chronic immune thrombozytopenia. Clinics in Hematology. Vol. 12, No. 1. Saunders; Philadelphia: 1983
    Google Scholar
  • 54 Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 1983; II: 193.
    PubMedGoogle Scholar
  • 55 Schmidt R E, Budde U, Schafer G, Stroehmann I. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet 1981; II: 475-6.
    PubMedGoogle Scholar
  • 56 Schulman I, Currimabhoy Z. Am J Dis Child. 1960; 100: 747.
    PubMedGoogle Scholar
  • 57 Seifried E, Pindur G, Stötter H, Wiesneth M. Treatment of refractory chronic idiopathic thrombocytopenic purpura with highdose intravenous immunoglobulin. Blut 1984; 48: 369-76.
    CrossrefPubMedGoogle Scholar
  • 58 Seitz C. Kurzgefaßtes Lehrbuch der Kinderheilkunde. 3. Aufl. Karger; Berlin: 1916
    Google Scholar
  • 59 Sugiura K, Steiner M, Baldini M G. Platelet antibody in idiopathic thrombozytopenic purpura and other thrombozytopenias. J Lab Clin Med 1980; 96: 640-53.
    PubMedGoogle Scholar
  • 60 Thompson R, Moore R, Hess C E. et al. Idiopathic thrombocytopenic purpura. Long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Int Med 1972; 130: 730-4.
    CrossrefPubMedGoogle Scholar
  • 61 Thum J. Immunglobuline : Schwierigkeiten bei der Auswahl. Krankenhauspharmazie 1985; 09: 374-8.
    PubMedGoogle Scholar
  • 62 von dem Borne A E G, Helmerhorst F M, van Lewyn E F. et al. Autoimmune thrombozytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test. Br J Haemat 1980; 45: 319-27.
    CrossrefPubMedGoogle Scholar
  • 63 Wenske C, Gaedicke G, Kuenzlen E. et al. Treatment of idiopathic thrombocytic purpura in pregnancy by high-dose intravenous immunoglobulin. Blut 1983; 46: 347-53.
    CrossrefPubMedGoogle Scholar
  • 64 Wenske G, Gaedicke G, Heyes H. Idiopathic thrombocytopenic purpura in pregnancy and neonatal period. Blut 1984; 48: 377-82.
    CrossrefPubMedGoogle Scholar
  • 65 Werlhof P G. Morbus maculosus haemorrhagicus, Excerpta e commercia novico 1731-1745; zit. nach: Schultz W. Die Purpuraerkrankungen. Ergebn Inn Med 1918; 16: 32-106.
    PubMedGoogle Scholar
  • 66 Woerner S J, Abildgaard Ch F, French B N. Intracranial hemorrhage in children with idiopathic thrombozytopenic purpura. Pediatrics 1981; 67: 453.
    PubMedGoogle Scholar
  • 67 Wintrobe M M. Thrombozytopenia in Clinical Hematology. 8th. ed. Lea & Febiger; Philadelphia: 1981: 1090-1127.
    Google Scholar